Cargando…
The potential role of nanomedicine on COVID-19 therapeutics
Autores principales: | Mainardes, Rubiana Mara, Diedrich, Camila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Newlands Press Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325497/ https://www.ncbi.nlm.nih.gov/pubmed/32594863 http://dx.doi.org/10.4155/tde-2020-0069 |
Ejemplares similares
-
Enhancing Oral Bioavailability and Brain Biodistribution of Perillyl Alcohol Using Nanostructured Lipid Carriers
por: Peczek, Samila Horst, et al.
Publicado: (2023) -
Application of a validated HPLC-PDA method for the determination of melatonin content and its release from poly(lactic acid) nanoparticles
por: Martins, Leiziani Gnatkowski, et al.
Publicado: (2017) -
Role of nanomedicine in COVID-19 therapeutics
por: Sharma, Smriti
Publicado: (2022) -
Resveratrol-Loaded Polymeric Nanoparticles: Validation of an HPLC-PDA Method to Determine the Drug Entrapment and Evaluation of Its Antioxidant Activity
por: da Rocha Lindner, Gabriela, et al.
Publicado: (2013) -
Optimized Chitosan-Based Nanoemulsion Improves Luteolin Release
por: Diedrich, Camila, et al.
Publicado: (2023)